Skip to main content
. 2022 Jul 18;9:825897. doi: 10.3389/fnut.2022.825897

Table 3.

Results of meta-regression analyses with age, BMI, country, and duration of intervention in all indexes (FBS, HbA1c, Insulin, HOMA-IR, TC, TG, HDL-C, LDL-C, SBP, and DBP) as independent variables.

n [95% CI] Coef. Std. Err. R2 p value
FBS
Age
 Years ≤ 55 7 [−1.829, 0.420] 0.460 1.121 −12.08% 0.686
 Years > 55 8
Baseline BMI
 BMI ≥ 30 10 [−0.956, 3.452] 1.248 1.049 −12.08% 0.250
 BMI <30 6
Country
 Eastern 12 [−4.096, 2.125] −0.986 1.480 −12.08% 0.514
 Western 6
Duration of intervention
  ≤ 8 wks 7 [−1.803, 2.041] 0.119 0.915 −12.08% 0.898
 8 < wks ≤ 12 6
 12 < wks ≤ 24 5
 >24 wks 4
HbA1c
Age
 Years ≤ 55 6 [−1.830, 0.421] −0.704 0.528 23.79% 0.202
 Years > 55 8
Baseline BMI
 BMI ≥ 30 6 [−1.531, 0.719] −0.406 0.528 23.79% 0.454
 BMI <30 8
Country
 Eastern 7 [−1.511, 1.579] 0.339 0.725 23.79% 0.963
 Western 9
Duration of intervention weeks
  ≤ 8 wks 4 [−1.570, 0.250] −0.660 0.427 23.79% 0.143
 8 < wks ≤ 12 3
 12 < wks ≤ 24 7
 >24 wks 4
Insulin
Age
 Years ≤ 55 5 [−1.096, 0.781] −0.157 0.383 −44.68% 0.696
 Years > 55 4
Baseline BMI
 BMI ≥ 30 3 [−0.485, 1.257] 0.386 0.356 −44.68% 0.320
 BMI <30 5
Country
 Eastern 7 [−1.301, 1.729] 0.214 0.619 −44.68% 0.741
 Western 4
Duration of intervention
  ≤ 8 wks 6 [−1.513, 1.266] −0.124 0.568 −44.68% 0.834
 8 < wks ≤ 12 5
 12 < wks ≤ 24 -
 >24 wks -
HMOA-IR
Age
 Years ≤ 55 6 [−0.376, 0.261] −0.057 0.115 - 0.643
 Years > 55 2
Baseline BMI
 BMI ≥ 30 1 [−0.341, 0.350] 0.004 0.124 - 0.973
 BMI <30 5
Country
 Eastern 8 [−0.435,1.055] 0.310 0.268 - 0.313
 Western 2
Duration of intervention
  ≤ 8 wks 4 [−0.344, 0.593] 0.125 0.169 - 0.501
 8 < wks ≤ 12 4
 12 < wks ≤ 24 1
 >24 wks -
TC
Age
 Years ≤ 55 6 [−1.833, 1.238] −0.297 0.698 3.37% 0.678
 Years > 55 5
Baseline BMI
 BMI ≥ 30 5 [−1.154, 2.287] 0.566 0.782 3.37% 0.484
 BMI <30 9
Country
 Eastern 9 [−2.940, 0.853] −1.043 0.862 3.37% 0.251
 Western 5
Duration of intervention
  ≤ 8 wks 6 [−1.867, 0.948] −0.460 0.639 3.37% 0.587
 8 < wks ≤ 12 4
 12 < wks ≤ 24 3
 >24 wks 3
TG
Age
 Years ≤ 55 6 [−1.508, 0.908] −0.299 0.554 −6.67% 0.599
 Years > 55 7
Baseline BMI
 BMI ≥ 30 5 [−0.929, 1.460] 0.265 0.548 −6.67% 0.638
 BMI <30 9
Country
 Eastern 8 [−2.217, 0.957] −0.630 0.728 −6.67% 0.404
 Western 7
Duration of intervention
  ≤ 8 wks 6 [−1.376, 0.804] −0.286 0.500 −6.67% 0.578
 8 < wks ≤ 12 5
 12 < wks ≤ 24 2
 >24 wks 4
HDL-C
Age
 Years ≤ 55 6 [−0.847, 1.312] 0.232 0.503 −28.26% 0.651
 Years > 55 8
Baseline BMI
 BMI ≥ 30 6 [−1.172, 1.041] −0.066 0.516 −28.26% 0.900
 BMI <30 10
Country
 Eastern 9 [−1.528, 1.117] −0.206 0.616 −28.26% 0.744
 Western 8
Duration of intervention
  ≤ 8 wks 6 [−0.907, 0.961] 0.027 0.436 −28.26% 0.952
 8 < wks ≤ 12 5
 12 < wks ≤ 24 4
 >24 wks 4
 LDL-C
Age
  Years ≤ 55 6 [−1.368, 1.068] −0.150 0.568 7.26% 0.796
 Years > 55 8
Baseline BMI
 BMI ≥ 30 6 [0.920, 1.568] 0.324 0.580 7.26% 0.585
 BMI <30 10
Country
 Eastern 9 [−2.546, 0.442] −1.051 0.697 7.26% 0.153
 Western 8
Duration of intervention
  ≤ 8 wks 6 [−1.318, 0.786] −0.266 0.490 7.26% 0.596
 8 < wks ≤ 12 5
 12 < wks ≤ 24 4
 >24 wks 4
SBP
Age
 Years ≤ 55 3 [−1.775, 2.962] 0.593 0.968 −8.81% 0.563
 Years > 55 4
Baseline BMI
 BMI ≥ 30 5 [−2.306, 3.352] 0.523 1.156 −8.81% 0.667
 BMI <30 4
Country
 Eastern 6 [−7.621, 2.777] −2.421 2.124 −8.81% 0.298
 Western 2
Duration of intervention
  ≤ 8 wks 4 [−2.539, 3.973] 0.717 1.330 −8.81% 0.609
 8 < wks ≤ 12 1
 12 < wks ≤ 24 2
 >24 wks 4
DBP
Age
 Years ≤ 55 3 [−0.551, 1.477] 0.463 0.414 −18.41% 0.306
 Years > 55 4
Baseline BMI
 BMI ≥ 30 5 [−1.057, 1.400] 0.172 0.502 −18.41% 0.744
 BMI <30 4
Country
 Eastern 6 [−3.322, 1.131] −1.095 0.910 −18.41% 0.274
 Western 2
Duration of intervention
  ≤ 8 wks 4 [−0.893, 1.931] 0.519 0.577 −18.41% 0.403
 8 < wks ≤ 12 1
 12 < wks ≤ 24 3
 >24 wks 2

CI, confidence interval; Coef, coefficient; Std. Err, standard error; R2, R Square.